farrerol has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Fu, R; Gao, H; Jia, L; Li, K; Lu, J; Ma, F; Ma, X; Tian, L; Wang, L; Yang, Y; Zhang, Y; Zhao, W | 1 |
1 other study(ies) available for farrerol and transforming growth factor beta
| Article | Year |
|---|---|
Farrerol alleviates high glucose-induced renal mesangial cell injury through the ROS/Nox4/ERK1/2 pathway.
Topics: Animals; Cell Line; Cell Survival; Chromones; Glucose; Interleukin-1beta; Interleukin-6; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 4; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta | 2020 |